Revvity, 3305-0010, GSP Neonatal 17α-OH-progesterone kit

Overview
These types represent 95% of CAH cases and in both, the 17α-OH progesterone (17OHP), a precursor of cortisol, is increased. The determination of 17OHP is thus a useful screening method for 95% of all CAH cases.
GSP Neonatal 17α-OH-progesterone assay
The GSP Neonatal 17α-OH-progesterone assay is intended for the quantitative determination of 17OHP in dried blood spot specimens as an aid in screening newborns for CAH.

Incubation time 3 h
Sensitive, robust DELFIA chemistry for confidence in results
Not affected by EDTA, citrate or heparin in samples
All reagents are ready to use
Contains reagents and plates for 1152 tests (12 plates) Application-Newborn Screening
Brand-GSP®
Detection Modality-Time-Resolved Fluorescence (TRF)
Disorders-Congenital Adrenal Hyperplasia (CAH)
Instrument Compatibility-GSP
Quantity-1152 tests
Regulatory Status-CE-IVD marked
Sample Type-Dried blood spots
Technology-DELFIA
Unit Size-12 plates